Vaccine Information: Typhim Vi (Page 4 of 4)

PRINCIPAL DISPLAY PANEL — 20 Dose Vial Package

NDC 49281-790-20

Typhoid Vi
Polysaccharide Vaccine
Typhim Vi®

Typh

multi-
dose vial (20 doses)

Rx only

SANOFI PASTEUR

PRINCIPAL DISPLAY PANEL -- 20 Dose Vial Package
(click image for full-size original)
TYPHIM VI salmonella typhi ty2 vi polysaccharide antigen injection, solution
Product Information
Product Type VACCINE Item Code (Source) NDC:49281-790
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN (SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN) SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN 25 ug in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 4.15 mg in 0.5 mL
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE 0.065 mg in 0.5 mL
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE 0.023 mg in 0.5 mL
PHENOL 1.25 mg in 0.5 mL
WATER 0.5 mL in 0.5 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49281-790-51 1 SYRINGE in 1 PACKAGE contains a SYRINGE (49281-790-88)
1 NDC:49281-790-88 0.5 mL in 1 SYRINGE This package is contained within the PACKAGE (49281-790-51)
2 NDC:49281-790-20 1 VIAL, MULTI-DOSE in 1 PACKAGE contains a VIAL, MULTI-DOSE (49281-790-38)
2 NDC:49281-790-38 10 mL in 1 VIAL, MULTI-DOSE This package is contained within the PACKAGE (49281-790-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA103936 11/28/1994
Labeler — Sanofi Pasteur Inc. (086723285)
Establishment
Name Address ID/FEI Operations
Sanofi Pasteur 578763542 MANUFACTURE (49281-790)

Revised: 01/2023 Sanofi Pasteur Inc.

Page 4 of 4 1 2 3 4

VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

https://vxlabels.com/lib/vaccines/vax/typhim-vi/page/4/

Clinical Trials

Vx Labels

Vaccine Sections

Vaccine Information by RSS

About

As the leading independent provider of trustworthy vaccine information, our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VxLabels.com provides the full vaccine subset of the FDA's repository. Vaccine information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.